Literature DB >> 18456741

Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.

K Oberg1, S Jelic.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18456741     DOI： 10.1093/annonc/mdn117

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses.

Authors:  P Ferolla; A Faggiano; F Grimaldi; D Ferone; G Scarpelli; V Ramundo; R Severino; M C Bellucci; L M Camera; G Lombardi; G Angeletti; A Colao
Journal:  J Endocrinol Invest       Date:  2011-07-13       Impact factor: 4.256

2.  Multifocality in Small Bowel Neuroendocrine Tumors.

Authors:  Alexandra Gangi; Emily Siegel; Galinos Barmparas; Simon Lo; Laith H Jamil; Andrew Hendifar; Nicholas N Nissen; Edward M Wolin; Farin Amersi
Journal:  J Gastrointest Surg       Date:  2017-11-08       Impact factor: 3.452

3.  Pancreatic cystic lesions: clinical predictors of malignancy in patients undergoing surgery.

Authors:  E S Huang; B G Turner; C Fernandez-Del-Castillo; W R Brugge; C Hur
Journal:  Aliment Pharmacol Ther       Date:  2009-10-21       Impact factor: 8.171
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.